MAST has been a manufacturer of antibiotic susceptibility test products since 1957 and continues to be at the forefront of developments in this field. MAST's original product was the single antibiotic disc, but the expansion of the portfolio has resulted in the most comprehensive range available worldwide. As a specialist microbiology company, MAST has an extensive range of Dehydrated Culture Media, and selective supplements for the culture, examination, selection, isolation and transport of clinically significant organisms from patient specimens.

In-vitro diagnostic products by ORGENTEC comprise more than 300 laboratory tests, primarily enzyme-linked immunosorbent assays (ELISA), that contribute to the diagnosis of rheumatic diseases, thrombosis, and diseases of the gastrointestinal tract, as well as infectious diseases. Their product portfolio also embraces the fully automated instrument Alegria® and associated test kits that enable laboratories to complete multiple assays and deliver faster results than traditional ELISA tests.

Nichipet® innovative liquid handling technologies are flexible and reliable. Their advanced designs will bring improved efficiency and safety to almost any life science laboratory workflow.

This product is a patented slide processor using dual membrane filtration method. HURO PATH® LBC Processor is designed diagnostics of both cervical cancer and Non-gynecological cancer.

The EXIAS e|1 Analyzer is an electrolyte system intended for in-vitro measurements of Na+, K+, Cl-, Ca2+ as well as pH and Hct, in whole blood, serum and plasma. High accuracy, ease of use and the maintenance free system underline the operational functionally and outstanding performance of our e|1 Analyzer. Robust and clever design combined with a compact footprint make the e|1 Analyzer well suited for both point-of-care environment and laboratory.

Nerbe plus GmbH was incorporated in 1976 by Jürgen F. Nerbe. Initially located in a suburb of Hamburg, this independent family business rapdly outgrey that facility and in 1992, moved to its present home in Winsen (Luhe) where it remains today. Utilizing its own an injection molding machine capabilities, the company initially targetted the plasticware consumables market in microbiology and the clinical laboratories. More recently, the next generation of the Nerbe family has changed the product focus to the rapidly growing sectors of liquid and sample handling, within life sciences, worldwide.

The LIOFeron®TB/LTBI IGRA is a novel test for diagnosing Latent TB Infection (LTBI)/TB. As for other Interferon Gamma Release Assay (IGRA) tests on the market, this test may react positive in TB patients also, but it can not differentiate between LTBI and active TB. The test is intended for professional in vitro diagnostic use. The test is NOT intended for personal use.